Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
BCAS1 resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Zusätzlich bieten wir Ihnen BCAS1 Antikörper (76) und BCAS1 Proteine (14) und viele weitere Produktgruppen zu diesem Protein an.
Two transcripts with regulation from days 7 to 28 in the 1-methyl-4-phenyl-tetrahydropyridine treated groups, are identified: brain specific (zeige CALY ELISA Kits) angiogenesis inhibitor associated protein 3 (zeige HSPB3 ELISA Kits) (Baiap3 (zeige BAIAP3 ELISA Kits)) and breast carcinoma amplified sequence 1 (Bcas1).
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.
breast carcinoma amplified sequence 1
, breast carcinoma-amplified sequence 1-like
, amplified and overexpressed in breast cancer
, breast carcinoma-amplified sequence 1
, novel amplified in breast cancer 1
, amplified in breast cancer 1
, breast carcinoma-amplified sequence 1 homolog
, novel amplified in breast cancer 1 homolog
, band 83